MetLife (NYSE:MET) Announces Earnings Results

MetLife (NYSE:MET) posted its quarterly earnings results on Wednesday. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05), Zacks reports. MetLife had a return on equity of 20.01% and a net margin of 5.27%.

MetLife Trading Down 1.8 %

NYSE MET traded down $1.52 on Thursday, reaching $83.48. 1,412,380 shares of the company were exchanged, compared to its average volume of 3,445,247. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The business’s fifty day moving average price is $83.90 and its 200 day moving average price is $80.71. The stock has a market capitalization of $57.80 billion, a P/E ratio of 16.83, a price-to-earnings-growth ratio of 0.66 and a beta of 1.07. MetLife has a fifty-two week low of $66.02 and a fifty-two week high of $89.05.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.61%. MetLife’s dividend payout ratio (DPR) is presently 43.95%.

Analysts Set New Price Targets

A number of analysts have commented on the company. Barclays lifted their price target on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Wells Fargo & Company dropped their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen upped their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Finally, JPMorgan Chase & Co. raised their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, MetLife has an average rating of “Moderate Buy” and a consensus price target of $91.17.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.